DaVita Inc
NYSE:DVA
DaVita Inc
NYSE:DVA
Price:
137.61 USD
2.35%
Updated:
May 6, 2024
DaVita Inc
Operating Income
|
DaVita Inc
Operating Income Peer Comparison
Comparables:
CHE
DGX
CVS
CI
LH
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
|
Chemed Corp
NYSE:CHE
|
Operating Income
$373.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$13.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is DaVita Inc's Operating Income?
Operating Income
1.6B
USD
1.6B
USD
Based on the financial report for Dec 31, 2023, DaVita Inc's Operating Income amounts to 1.6B USD.
What is DaVita Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-1%
-1%
Over the last year, the Operating Income growth was 22%. The average annual Operating Income growth rates for DaVita Inc have been -2% over the past three years , 1% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
